Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sculpher

Showing results (141-150 of 174) with videos related to

Pageof 18
Sort By:
European Journal of Haematology|December 17, 2013
Cost-effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trialEldon Spackman, Mark Sculpher, Jo Howard, et al.
Open Heart|October 29, 2014
Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE studyStephen Brecker, Stuart Mealing, Amie Padhiar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value FrameworkDaniel C Malone, Nancy S Berg, Karl Claxton, et al.
Medical Care|May 26, 2011
Determinants of the cost of health services used by veterans with HIVPaul G Barnett, Adam Chow, Vilija R Joyce, et al.
Health Technology Assessment (Winchester, England)|November 2, 2024
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment modelSue Harnan, Ben Kearns, Alison Scope, et al.
Clinical Pharmacology and Therapeutics|January 19, 2026
Reply to "On Selection and Analytical Transparency in the FRAME Framework for RWE Evaluation"Gianmario Candore, Claire Martin, Mackenzie J Mills, et al.
Clinical Pharmacology and Therapeutics|June 10, 2025
FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision MakingGianmario Candore, Claire Martin, Mack J Mills, et al.
Pharmacoeconomics|January 19, 2013
Acknowledging patient heterogeneity in economic evaluation : a systematic literature reviewJanneke P C Grutters, Mark Sculpher, Andrew H Briggs, et al.
Trials|July 31, 2009
Clinical evaluation of magnetic resonance imaging in coronary heart disease: the CE-MARC studyJohn P Greenwood, Neil Maredia, Aleksandra Radjenovic, et al.
Health Technology Assessment (Winchester, England)|December 6, 2016
The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluationDiane Farrar, Mark Simmonds, Susan Griffin, et al.
Pageof 18

Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
European Journal of Haematology|December 17, 2013
Cost-effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trialEldon Spackman, Mark Sculpher, Jo Howard, et al.
Open Heart|October 29, 2014
Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE studyStephen Brecker, Stuart Mealing, Amie Padhiar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value FrameworkDaniel C Malone, Nancy S Berg, Karl Claxton, et al.
Medical Care|May 26, 2011
Determinants of the cost of health services used by veterans with HIVPaul G Barnett, Adam Chow, Vilija R Joyce, et al.
Health Technology Assessment (Winchester, England)|November 2, 2024
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment modelSue Harnan, Ben Kearns, Alison Scope, et al.
Clinical Pharmacology and Therapeutics|January 19, 2026
Reply to "On Selection and Analytical Transparency in the FRAME Framework for RWE Evaluation"Gianmario Candore, Claire Martin, Mackenzie J Mills, et al.
Clinical Pharmacology and Therapeutics|June 10, 2025
FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision MakingGianmario Candore, Claire Martin, Mack J Mills, et al.
Pharmacoeconomics|January 19, 2013
Acknowledging patient heterogeneity in economic evaluation : a systematic literature reviewJanneke P C Grutters, Mark Sculpher, Andrew H Briggs, et al.
Trials|July 31, 2009
Clinical evaluation of magnetic resonance imaging in coronary heart disease: the CE-MARC studyJohn P Greenwood, Neil Maredia, Aleksandra Radjenovic, et al.
Health Technology Assessment (Winchester, England)|December 6, 2016
The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluationDiane Farrar, Mark Simmonds, Susan Griffin, et al.
Pageof 18